Ron Squarer's Trading History
| NUVLNuvalent | Jun 18, 2026 | ― | Uninformative Buy | ― | $778.59K | |
| ADCTADC Therapeutics | Jun 03, 2026 | Director | Uninformative Buy | ― | $188.85K | |
| TVTXTravere Therapeutics | May 21, 2026 | Director | Uninformative Buy | ― | $1.98M | |
| ~ARRYArray Biopharma | Jul 30, 2019 | ― | Uninformative Sell | 12.47M | $0.00 | |
| ARRYArray Technologies | Apr 03, 2019 | CEO, Director | Uninformative Buy | 521.08K | $881.03K | |
| HSPHospira Inc | Feb 28, 2011 | ― | Uninformative Buy | ― | $0.00 | |
| DCPHDeciphera Pharmaceuticals | ― | ― | ― | ― |
You May Also Like
Ron Squarer insider profile FAQ
What stocks does Ron Squarer hold?
Ron Squarer holds: ADCT, ~ARRY, TVTX, DCPH, ARRY, NUVL, HSP stocks.
What is Ron Squarer's role in ADC Therapeutics?
Ron Squarer's role in ADC Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.